Dr. Paolo Rossato

Paolo is a pharmaceutical scientist with long experience in Pharma companies and also in a Contract Research Organization. Currently he works at CSL Behring in the PK & QSP Unit of the Department of Pharmacology & Toxicology, providing ADME, PK, and PK/PD support for research programs in different therapeutic areas. After his degree in Chemistry, Paolo worked for more than 20 years in GlaxoSmithKline in the Drug Metabolism and Pharmacokinetics Department, in both Discovery and Development phases, mainly in CNS diseases and small molecules. Over the years, he covered almost all the roles in the Department (LC-MS Bioanalyst, Pharmacokineticist, Toxicokineticist and Study Director). He was also Laboratory Head with the responsibility of almost all in vitro and in vivo DMPK/ADME studies. He was a Senior Scientist in PK, PK/PD and TK data analysis, modeling and simulation and DMPK Project Representative in different Project Teams, in various therapeutic areas. After this experience, he worked for 3 years in a Contract Research Organization, Aptuit, always in the DMPK Department. Here he expanded his experience in almost all therapeutic areas and types of molecules. Then, Paolo joined Baxter/Baxalta/Shire and finally Takeda in the Pharmacology Department of Drug Discovery, where he focused for 6 years on biologics mainly in the Hematology area. He was responsible for all in vitro and in vivo DMPK/ADME studies, worked as non-clinical project team member and was involved in non-clinical due diligence evaluations to support in-licensing.